JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB237367

FITC Anti-CD8 alpha antibody [EPR21769]

Be the first to review this product! Submit a review

|

(9 Publications)

Rabbit Recombinant Monoclonal CD8 alpha antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 9 publications.

View Alternative Names

CD8a, Lyt-2, Lyt2, Cd8a, T-cell surface glycoprotein CD8 alpha chain, T-cell surface glycoprotein Lyt-2

1 Images
Flow Cytometry - FITC Anti-CD8 alpha antibody [EPR21769] (AB237367)
  • Flow Cyt

Unknown

Flow Cytometry - FITC Anti-CD8 alpha antibody [EPR21769] (AB237367)

C57BL/6 mouse splenocytes stained with ab237367 (right) or Rabbit IgG FITC (monoclonal) (left). C57BL/6 Mouse splenocytes were incubated for 30 mins on ice in 1x PBS containing 10 μg/ml anti CD16/32 antibody and 10% normal goat serum to block FC receptors and non-specific protein-protein interactions followed by the antibody (ab237367) or Rabbit IgG FITC Isotype (1x106 in 100 μl at 1 : 500 (1 μg/ml)) for 30 mins on ice. The cells were simultaneously stained with CD4 PerCP conjugated antibody.

Acquisition of >50,000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter. Events were gated on viable lymphocytes.

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-CD8 alpha antibody [EPR21769]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CD8 alpha antibody [EPR21769]

  • 660 APC

    APC Anti-CD8 alpha antibody [EPR21769]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CD8 alpha antibody [EPR21769]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CD8 alpha antibody [EPR21769]

  • 578 PE

    PE Anti-CD8 antibody [EPR21769]

  • Unconjugated

    Anti-CD8 alpha antibody [EPR21769]

  • Carrier free

    Anti-CD8 alpha antibody [EPR21769] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21769

Isotype

IgG

Conjugation

FITC

Excitation/Emission

Ex: 495nm, Em: 519nm

Carrier free

No

Reacts with

Mouse

Applications

Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD8 alpha also known as CD8A or CD8 protein is a glycoprotein subunit expressed on the surface of cytotoxic T lymphocytes. It has a mass of approximately 32 kDa. Found on the surface cell membrane CD8 alpha functions primarily in the immune response specifically in the recognition of antigens bound to major histocompatibility complex (MHC) class I molecules. Often scientists use CD8 antibodies for detection and CD8 IHC or immunohistochemistry for localization studies.
Biological function summary

The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.

Pathways

CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha’s role in adaptive immunity.

CD8 alpha is most prominently associated with viral infections and cancer. Conditions like HIV and some forms of leukemia show altered CD8 function highlighting the protein's role in immune surveillance. In HIV infection for instance CD8 T cells reduce in number impairing the immune response. CD8 alpha’s connection to the immune system places it alongside other immune proteins such as CD4 and MHC molecules in the context of immune dysfunction.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class I molecule : peptide complex. The antigens presented by class I peptides are derived from cytosolic proteins while class II derived from extracellular proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class I proteins presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of cytotoxic T-lymphocytes (CTLs). This mechanism enables CTLs to recognize and eliminate infected cells and tumor cells. In NK-cells, the presence of CD8A homodimers at the cell surface provides a survival mechanism allowing conjugation and lysis of multiple target cells. CD8A homodimer molecules also promote the survival and differentiation of activated lymphocytes into memory CD8 T-cells.
See full target information Cd8a

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

The Journal of clinical investigation 135: PubMed40759576

2025

ST8Sia6 overexpression protects pancreatic β cells from spontaneous autoimmune diabetes in nonobese diabetic mice.

Applications

Unspecified application

Species

Unspecified reactive species

Justin Choe,Paul Belmonte,Sydney Crotts,Thanh Nguyen,David Friedman,Alexi Zastrow,Matthew Rajcula,Brady Hammer,Claire Wilhelm,Michael J Shapiro,Aleksey Matveyenko,Virginia Smith Shapiro

Journal of pharmaceutical analysis 15:101181 PubMed40337128

2025

A novel exploration of 's role in regulating myeloid-derived suppressor cell activation within the colon cancer microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Niu,Xiaxia Du,Yang Song,Lianyi Guo,Baohai Liu,Xin Tong

Cell biology and toxicology 41:82 PubMed40335763

2025

ELF4 improves sepsis-induced myocardial injury by regulating STING signaling-mediated T cells differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Yawen Zheng,Xiongjun Peng,Yusha Zhang,Ruilin Liu,Junke Long

Breast cancer research : BCR 27:31 PubMed40045365

2025

Unveiling the key mechanisms of FOLR2+ macrophage-mediated antitumor immunity in breast cancer using integrated single-cell RNA sequencing and bulk RNA sequencing.

Applications

Unspecified application

Species

Unspecified reactive species

Sixuan Wu,Baohong Jiang,Zhimin Li,Yuanbin Tang,Lunqi Luo,Wenjie Feng,Yiling Jiang,Yeru Tan,Yuehua Li

Journal of biochemical and molecular toxicology 38:e23842 PubMed39588744

2024

Role of PD-1 in modulating IFN-γ-CXCL9/10-CXCR3 signaling in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Hong,Fang Huang,Zexian Hu,Qian Dong,Yan Kong,Xuan Zheng,Man Li,Yanzhi Cui

Clinical and translational medicine 14:e1800 PubMed39305055

2024

IFIT3 mediates TBK1 phosphorylation to promote activation of pDCs and exacerbate systemic sclerosis in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangyang Huang,Yi Liu,Xia Rong,Yiheng Zhao,Dan Feng,Jun Wang,Wanhong Xing

Immunotherapy 16:975-985 PubMed39115961

2024

The development of anti-PD-1 antibody-induced spinal cord injury in bone marrow transplant C57BL/6 mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Huachun Chen,Zhouxiao Lu,Xiaowei Ni,Hui Zhang,Guiyuan Chen,Xiaoyu Wu,Mingxing Ding

Cell death & disease 15:69 PubMed38238314

2024

The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Tang,Shasha Yin,Hongliang Zeng,Ao Huang,Yujia Huang,Zhiyi Hu,Ab Rauf Shah,Shuyong Zhang,Haisen Li,Guofang Chen

American journal of cancer research 13:5218-5235 PubMed38058799

2023

TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Wenmin Ji,Wenyan Wang,Yanfang Wei
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com